AMLX
Price
$9.42
Change
-$0.03 (-0.32%)
Updated
Aug 28 closing price
Capitalization
839.96M
69 days until earnings call
XOMAP
Price
$26.20
Change
-$0.23 (-0.87%)
Updated
Aug 28 closing price
Capitalization
N/A
Interact to see
Advertisement

AMLX vs XOMAP

Header iconAMLX vs XOMAP Comparison
Open Charts AMLX vs XOMAPBanner chart's image
Amylyx Pharmaceuticals
Price$9.42
Change-$0.03 (-0.32%)
Volume$1.49M
Capitalization839.96M
XOMA
Price$26.20
Change-$0.23 (-0.87%)
Volume$1.14K
CapitalizationN/A
AMLX vs XOMAP Comparison Chart in %
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. XOMAP commentary
Aug 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Buy and XOMAP is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 29, 2025
Stock price -- (AMLX: $9.42 vs. XOMAP: $26.20)
Brand notoriety: AMLX and XOMAP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 90% vs. XOMAP: 81%
Market capitalization -- AMLX: $839.96M vs. XOMAP: $0
AMLX [@Biotechnology] is valued at $839.96M. XOMAP’s [@Biotechnology] market capitalization is $0. The market cap for tickers in the [@Biotechnology] industry ranges from $100.52B to $0. The average market capitalization across the [@Biotechnology] industry is $1.84B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileXOMAP’s FA Score has 1 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • XOMAP’s FA Score: 1 green, 4 red.
According to our system of comparison, AMLX is a better buy in the long-term than XOMAP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 4 TA indicator(s) are bullish while XOMAP’s TA Score has 3 bullish TA indicator(s).

  • AMLX’s TA Score: 4 bullish, 4 bearish.
  • XOMAP’s TA Score: 3 bullish, 4 bearish.
According to our system of comparison, AMLX is a better buy in the short-term than XOMAP.

Price Growth

AMLX (@Biotechnology) experienced а +11.74% price change this week, while XOMAP (@Biotechnology) price change was +1.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.14%. For the same industry, the average monthly price growth was +15.09%, and the average quarterly price growth was +29.14%.

Reported Earning Dates

AMLX is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Biotechnology (-1.14% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMLX YTD gains are higher at: 149.206 vs. XOMAP (7.814). XOMAP has higher annual earnings (EBITDA): -305K vs. AMLX (-196.3M). AMLX has more cash in the bank: 181M vs. XOMAP (83.9M). AMLX has less debt than XOMAP: AMLX (5.96M) vs XOMAP (115M). XOMAP has higher revenues than AMLX: XOMAP (12.8M) vs AMLX (-249K).
AMLXXOMAPAMLX / XOMAP
Capitalization840MN/A-
EBITDA-196.3M-305K64,360%
Gain YTD149.2067.8141,909%
P/E Ratio2.69N/A-
Revenue-249K12.8M-2%
Total Cash181M83.9M216%
Total Debt5.96M115M5%
TECHNICAL ANALYSIS
Technical Analysis
AMLXXOMAP
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
11%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
26%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
28%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
26%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
26%
Advances
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 5 days ago
23%
Declines
ODDS (%)
Bearish Trend 12 days ago
81%
Bearish Trend 24 days ago
19%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
12%
Aroon
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
10%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
XOMAP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSPIX71.05N/A
N/A
NYLI S&P 500 Index Class I
NQVCX56.13N/A
N/A
Nuveen Multi Cap Value C
AEIUX9.08N/A
N/A
American Century Equity Income R5
GNXAX16.93N/A
N/A
AlphaCentric Robotics and Automation A
SVXAX68.38N/A
N/A
Smead International Value A

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
-0.32%
XOMAO - AMLX
68%
Closely correlated
-0.27%
XOMAP - AMLX
51%
Loosely correlated
-0.86%
RGNX - AMLX
46%
Loosely correlated
+2.15%
ADVM - AMLX
44%
Loosely correlated
-0.33%
LRMR - AMLX
44%
Loosely correlated
+0.26%
More

XOMAP and

Correlation & Price change

A.I.dvisor indicates that over the last year, XOMAP has been loosely correlated with AMLX. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if XOMAP jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To XOMAP
1D Price
Change %
XOMAP100%
-0.86%
AMLX - XOMAP
51%
Loosely correlated
-0.32%
CGEN - XOMAP
31%
Poorly correlated
-4.76%
RNAC - XOMAP
29%
Poorly correlated
-3.25%
XOMAO - XOMAP
27%
Poorly correlated
-0.27%
MGTX - XOMAP
26%
Poorly correlated
+0.67%
More